Tvardi Therapeutics, Inc. (TVRD)
1.82
+0.02
(+1.11%)
USD |
NASDAQ |
Aug 28, 16:00
1.81
-0.01
(-0.55%)
After-Hours: 20:00
Tvardi Therapeutics Debt to Equity Ratio : 0.0173 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0173 |
| March 31, 2026 | 0.012 |
| December 31, 2025 | 0.0096 |
| September 30, 2025 | 0.0082 |
| June 30, 2025 | 0.0077 |
| March 31, 2025 | -5.676 |
| December 31, 2024 | -5.430 |
| September 30, 2024 | 62.23 |
| June 30, 2024 | 4.067 |
| March 31, 2024 | 1.524 |
| December 31, 2023 | 0.7562 |
| September 30, 2023 | 0.0854 |
| June 30, 2023 | 0.009 |
| March 31, 2023 | 0.0107 |
| December 31, 2022 | 0.0121 |
| September 30, 2022 | 0.0128 |
| June 30, 2022 | 0.0138 |
| March 31, 2022 | 0.0159 |
| December 31, 2021 | 0.0161 |
| September 30, 2021 | 0.0162 |
| June 30, 2021 | 0.0221 |
| March 31, 2021 | 0.0212 |
| December 31, 2020 | 0.0212 |
| September 30, 2020 | 0.0291 |
| June 30, 2020 | 0.0281 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0255 |
| December 31, 2019 | 0.0231 |
| September 30, 2019 | 0.0215 |
| June 30, 2019 | 0.0479 |
| March 31, 2019 | 0.0436 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly & Co. | 1.621 |
| Crinetics Pharmaceuticals, Inc. | 0.0396 |
| Liquidia Corp. | 0.9374 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 17.52M |
| Total Liabilities (Quarterly) | 9.135M |
| Shareholders Equity (Quarterly) | 8.382M |
| Current Ratio | 1.873 |
| Net Debt Paydown Yield | 51.25% |